US Readies 100% Tariffs on Medicines Affecting Pharma Market

The U.S. plans to impose new tariffs of 100% on certain pharmaceuticals, following threats made by former President Trump last year. This decision could significantly impact pharmaceutical companies and their pricing structures. While the list of specific medicines has not been released, the tariffs may affect trade dynamics and pricing in the pharmaceutical sector. Market participants will need to monitor how these levies may influence supply chains and costs for companies in the industry.